Being global first reference in preservation and transport of organs and biological products with high impact revolutionary solutions.


Transplant Biomedicals is a European company based in Barcelona aimed at developing novel medical strategies to improve organ, tissue and cellular preservation to overall enhance patients´ wellness.

Our values are at the basis of all our organizations actions

  • Fight for our cause, the patient
  • Trust and commitment
  • Innovation, entrepreneurship, creativity and passion
  • Superior quality that meets needs and provides sustainable added value



Transplant Biomedicals is developing a new organ transport device available for hospital use. The device uses a revolutionary technology leading to superior preservation of the organs during transport from the donor hospital to the transplant center.

Our high quality and convenient product aims to become the global gold standard for transplant centers by reducing the risk of delayed graft function, improving graft survival and as such leading to better patient outcomes. In addition, our product has the potential to use part of the marginal organs that are currently discarded and thus reduce the waiting lists. [3D conceptual model]

“Our challenge is to achieve the perfection in our products to provide our users with solutions that guarantee excellence in the results of their invaluable work.”

Ignasi Heras – Chief Executive Officer


Ignasi Heras, MBA

Chief Executive Officer

Mr Heras is co-founder of Transplant Biomedicals. He has a long experience in the biomedical and biotechnology arena in business development and innovation, including public and private companies.

More information: LinkedIn

Carmen Peralta_Transplant_Biomedicals
Dra. Carmen Peralta

Chief Scientific Officer

Dr. Peralta is co-founder of Transplant Biomedicals. She is Senior Group Leader at IDIBAPS. Her expertise focuses in pharmacological and surgical strategies aimed at reducing hepatic ischemia/reperfusion injury associated with hepatic resections and liver transplantation.

More information: LinkedIn

Miguel Angel Gomez
Miguel Angel Gomez

Chief Technology Officer

Mr. Miguel Angel has more than 20 years of experience in the development of medical devices in management positions in I&D, quality, regulation and production.

Jordi Petit, MBA

Chief Financial Officer

Mr. Petit has worked during more than 25 years in different financial directive positions in both multinational and start-ups of recent creation in the life science sector.

More information: LinkedIn

Eva Maria Nyakern
Dr. Eva Maria Nyakern

Chief Clinical Officer

Dr. Eva Maria is a medical device professional with a broad understanding of the clinical development and commercialization process. She has worked in management positions at medical device start-ups and for global companies.

More information: LinkedIn

Montse Gutiérrez Transplant Biomedicals
Montse Gutiérrez

QA&RA Manager

Ms. Montse Gutiérrez has an extensive knowledge in Quality and Regulatory Affairs in Medical Device due to over more than 12 years of experience in a Notified Body as Auditor and Technical Director and during the last 5 years in the electromedicine, cosmetic and dental industry.

More information: LinkedIn

Marc Cusachs Transplant Biomedicals
Marc Cusachs

Business Development Manager

Mr. Marc Cusachs joined Transplant Biomedicals in 2015 as Business Developer, he holds a BSc in Biotechnology from Universitat de Girona and a Master in Business Management applied to the biomedicine industry from Universitat de Barcelona.

More information: LinkedIn

Board of Directors

Ignasi Heras, MBA

More information: LinkedIn

Dra. Carmen Peralta

More information: LinkedIn

Joaquin Sanz Berrioategortua
Joaquin Sanz Berrioategortua

More information: LinkedIn

Alex Casta
Alex Casta

More information: LinkedIn

Advisory Board

Prof. Juan Rodés 2017

More information: Wikipedia

Dr. Enrique Castellón

More information: LinkedIn

Dr. Blanca Miranda
Silvina Ramella
Dra. Silvina Ramella

More information: LinkedIn

Raj Airey
Sr. Raj Airey

More information: LinkedIn


Transplant Biomedicals is backed by specialized national venture capital. These investors include Caixa Capital Risc and Kereon Partners and several private investors. To date, Transplant Biomedicals has raised over €4M.



Transplant Biomedicals S.L.
Marie Curie, 8-14
Barcelona Advanced Industry Park
08042 Barcelona [Spain]
+34 935 27 27 20


January 2th 2017
Transplant Biomedicals closes €2.5M in Series A financing by Caixa Capital Risc and Kereon Partners. More information

November 11th 2016
Transplant Biomedicals raises €1.5M. More information.

If you want to invest in Transplant Biomedicals, please email us at: